Physicians who refer privately insured patients to themselves or members of their own specialty for imaging exams order them more frequently than physicians who send patients to radiologists, according to Massachusetts General Hospital researchers.
Physicians who refer privately insured patients to themselves or members of their own specialty for imaging exams order them more frequently than physicians who send patients to radiologists, according to Massachusetts General Hospital researchers.
Principal investigator Dr. G. Scott Gazelle, director of MGH's Institute of Technology Assessment, and colleagues analyzed more than 526 million claims filed between 1999 and 2003. Investigators sought out the provider of the professional interpretation and organized data according to six conditions: cardiopulmonary disease, cardiovascular disease, extremity fracture, knee pain, intra-abdominal malignancy, and stroke. They then categorized each physician's proclivity to self-refer studies or refer them to radiologists (Radiology 2007 Nov;245[2]: 517-522).
Researchers found that self-referring physicians use imaging about twice as often as those who send their patients to radiologists. They also found that patient age and comorbidity do not explain the increased frequency for self-referred imaging.
Four Strategies to Address the Tipping Point in Radiology
January 17th 2025In order to flip the script on the impact of the radiology workforce shortage, radiology groups and practices need to make sound investments in technologies and leverage partnerships to mitigate gaps in coverage and maximize workflow efficiencies.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI-Based AI Enhance Risk Stratification in Prostate Cancer?
January 13th 2025Employing baseline MRI and clinical data, an emerging deep learning model was 32 percent more likely to predict the progression of low-risk prostate cancer (PCa) to clinically significant prostate cancer (csPCa), according to new research.